(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 27.93% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Personalis's revenue in 2026 is $69,648,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,522,053,453, with the lowest PSNL revenue forecast at $7,998,057,238, and the highest PSNL revenue forecast at $9,179,664,517. On average, 9 Wall Street analysts forecast PSNL's revenue for 2027 to be $11,639,244,992, with the lowest PSNL revenue forecast at $10,182,142,099, and the highest PSNL revenue forecast at $12,843,557,378.
In 2028, PSNL is forecast to generate $15,560,846,055 in revenue, with the lowest revenue forecast at $14,949,796,156 and the highest revenue forecast at $16,018,087,161.